Lagos Approves 14 Off-Grid, Metering Electricity Operators • Channels Television

  A total of 14 electricity licences and permits across off-grid generation, embedded generation, independent distribution, metering services, and interconnected mini-grid operations have been approved by the Lagos State Government.  The approvals were issued by the Lagos State Electricity Regulatory Commission (LASERC) at its maiden stakeholder engagement earlier in the week. The licensing exercise is…

Read Full News

Tinubu Approves ₦1.85bn For Education, Rehabilitation Of Rescued Chibok Girls • Channels Television

    President Bola Tinubu has reaffirmed his administration’s commitment to the education and rehabilitation of the rescued Chibok girls, approving a total of ₦1.85 billion to sustain their academic and welfare support until 2027. The Ministry of Education, in a statement on Thursday, explained that the government has so far committed ₦1,854,277,768 to cover…

Read Full News

BREAKING: Nigerian Police Commission Approves Promotion Of Over 900 Officers From ASP To DSP Rank

No fewer than 951 officers of the Nigeria Police Force have been promoted following approval by the Police Service Commission (PSC), SaharaReporters can report.  This was contained in an internal police wireless message obtained by SaharaReporters and issued from the Force Headquarters, Abuja. Hundreds of the officers were promoted from the rank of Assistant Superintendent…

Read Full News

US approves $346 million sale of bombs, rockets, precision munitions to Nigeria

The US State Department has approved the sale of munitions, precision-guided bombs, and rockets estimated to be potentially up to $346 million to Nigeria. The Defence Security Cooperation Agency (DSCA) disclosed this in a statement on Wednesday, according to Reuters. According to the DSCA, the request was granted following the Nigerian government’s request for a…

Read Full News

FDA Approves Merck RSV Shot for Infants — Despite High Rates of Serious Reactions

The U.S. Food and Drug Administration has recently approved clesrovimab, Merck’s new shot touted to “protect” infants against respiratory syncytial virus (RSV).1 This approval comes despite clinical trials showing adverse reactions associated with the shot. What’s more, clesrovimab is designed to be given in a single dose, unlike previously approved RSV shots, which are given…

Read Full News